Environmental and Nutritional Parameters Modulating Genetic Expression for Virulence Factors of Clostridioides difficile
- PMID: 38667041
- PMCID: PMC11047382
- DOI: 10.3390/antibiotics13040365
Environmental and Nutritional Parameters Modulating Genetic Expression for Virulence Factors of Clostridioides difficile
Abstract
Clostridioides difficile infections (CDIs) continue to be a persistent healthcare concern despite newer antibiotic treatments, enhanced infection control practices, and preventive strategies focused on restoring the protective intestinal microbial barrier. Recent strides in gene sequencing research have identified many genes regulating diverse virulence factors for CDIs. These genes may be over- or under-expressed when triggered by various environmental and nutritional factors. The aims of this paper are to review the important genes involved in C. difficile pathogenesis and to identify modifiable environmental, nutritional, and other factors that may trigger the expression of these genes and thus offer new strategies to prevent CDIs.
Keywords: CDI; Clostridioides difficile; antibiotics; environmental factors; gene expression; probiotics; virulence.
Conflict of interest statement
M.M. and S.G. are paid employees of Bio-K+/Kerry. L.V.M. is a member of the advisory board of Bio-K+/Kerry. The remaining authors (Z.M., M.L.) declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections.Microorganisms. 2023 Jun 9;11(6):1534. doi: 10.3390/microorganisms11061534. Microorganisms. 2023. PMID: 37375036 Free PMC article. Review.
-
Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems.Microb Pathog. 2021 Apr;153:104798. doi: 10.1016/j.micpath.2021.104798. Epub 2021 Feb 18. Microb Pathog. 2021. PMID: 33609647 Review.
-
Antibiotic Resistances of Clostridioides difficile.Adv Exp Med Biol. 2024;1435:169-198. doi: 10.1007/978-3-031-42108-2_9. Adv Exp Med Biol. 2024. PMID: 38175476
-
Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents.Pathogens. 2021 May 24;10(6):649. doi: 10.3390/pathogens10060649. Pathogens. 2021. PMID: 34073695 Free PMC article. Review.
-
Clostridioides difficile, a New "Superbug".Microorganisms. 2023 Mar 26;11(4):845. doi: 10.3390/microorganisms11040845. Microorganisms. 2023. PMID: 37110267 Free PMC article.
Cited by
-
Inhibitory effects of Levilactobacillus brevis IBRC-M10790 on apoptosis and inflammation induced by Clostridioides difficile culture supernatant in vitro.Sci Rep. 2025 Jun 13;15(1):20069. doi: 10.1038/s41598-025-04975-5. Sci Rep. 2025. PMID: 40514400 Free PMC article.
References
-
- Centers for Communicable Diseases (CDC) National and State Healthcare-Associated Infections Progress Report. [(accessed on 2 February 2023)];2020 Available online: https://www.cdc.gov/hai/data/portal/progress-report.html.
-
- Wiuff C., Banks A.L., Fitzpatrick F., Cottom L. Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology. Volume 1050. Springer; Cham, Switzerland: 2018. The need for European surveillance of CDI; pp. 13–25. - PubMed
-
- Feuerstadt P., Boules M., Strong L., Dahdal D.N., Sacks N.C., Lang K., Nelson W.W. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis. SAGE Open Med. 2021;9:2050312120986733. doi: 10.1177/2050312120986733. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases